[CAS NO. 1333714-43-4]  (Rac)-Benpyrine

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1333714-43-4]

Catalog
HY-133807A
Brand
MCE
CAS
1333714-43-4

DESCRIPTION [1333714-43-4]

Overview

MDL-
Molecular Weight308.34
Molecular FormulaC16H16N6O
SMILESO=C1N(CC2=CC=CC=C2)CC(NC3=C4N=CNC4=NC=N3)C1

For research use only. We do not sell to patients.

Summary

(Rac)-Benpyrine, a racemate of Benpyrine, is a potent and orally active TNF-α inhibitor. (Rac)-Benpyrine has the potential for TNF-α mediated inflammatory and autoimmune disease research [1] .


In Vitro

(Rac)-Benpyrine (Compound 001; 5-10 μM; 24 hours) treatment inhibits the expression level of TNF-α downstream pathway protein NF-κB in the nucleus in RAW264.7 macrophages [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


In Vivo

(Rac)-Benpyrine (Compound 001; 25-50 mg/kg; oral gavage; daily; for 3 weeks; Kunming mice) treatment obviously reduces the inflammatory cytokines IFN-γ, IL-1β and IL-6 in the blood serum, and the anti-inflammatory factor IL-10 is obviously increased, the foot swelling degree of the arthritis part is also obviously slowed down, and the weight index increase caused by the arthritis also has no obvious reduction [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Kunming mice (7-8 weeks) treated with bovine type II collagen and a CFA complete adjuvant [1]
Dosage: 25 mg/kg, 50 mg/kg
Administration: Oral gavage; daily; for 3 weeks
Result: The inflammatory cytokines IFN-γ, IL-1β and IL-6 in the blood serum were obviously reduced, and the anti-inflammatory factor IL-10 was obviously increased.

Appearance

Solid


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

4°C, protect from light

* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)


Solvent & Solubility

In Vitro:

DMSO : 12.5 mg/mL ( 40.54 mM ; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 3.2432 mL 16.2159 mL 32.4317 mL
5 mM 0.6486 mL 3.2432 mL 6.4863 mL
10 mM 0.3243 mL 1.6216 mL 3.2432 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: ≥ 1.25 mg/mL (4.05 mM); Clear solution

  • 2.

    Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

    Solubility: ≥ 1.25 mg/mL (4.05 mM); Clear solution

  • 3.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: ≥ 1.25 mg/mL (4.05 mM); Clear solution

* All of the co-solvents are available by MCE.